Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tertiary Healthcare System

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care...

Protein and Protein Structure

Protein and Protein Structure

Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Nomenclature of Secondary and Tertiary Amines

Nomenclature of Secondary and Tertiary Amines

The secondary and tertiary amines are derivatives of ammonia, where two and three of its hydrogens are replaced by alkyl groups, respectively. Secondary and tertiary amines can be symmetrical with identical alkyl groups attached to the nitrogen atom or unsymmetrical when more than one type of alkyl group is present. The standard nomenclature of secondary and tertiary amines is similar to the names given to the primary amines. They are generally named alkylamines. As depicted in Figure 1, for...

Lymphoid Cells and Tissues

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Functional screening of TCR-like antibodies using STAR-T cell library for cancer immunotherapy.

EMBO molecular medicine·2026

Same author

Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity.

Signal transduction and targeted therapy·2026

Same author

Fueling the fire: aspartate deficiency primes and fuels STING activation.

The Journal of clinical investigation·2026

Same author

IL-12 augments adoptive cell therapy by reshaping CD8<sup>+</sup> T dynamics and broadening antitumor immunity.

Cancer letters·2026

Same author

Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity.

Science advances·2026

Same author

Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistance.

Signal transduction and targeted therapy·2026

Search research articles

Related Experiment Video

Updated: Feb 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.

Haidong Tang¹, Xiangyan Qiu², Casey Timmerman²

¹Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Haidong.Tang@UTSouthwestern.edu.

Methods in Molecular Biology (Clifton, N.J.)

|August 25, 2018

Summary

This summary is machine-generated.

Tertiary lymphoid structures (TLS) can enhance antitumor immunity by promoting lymphocyte infiltration and activation within tumors. Targeting TLS offers a promising strategy for improving cancer immunotherapy efficacy.

Keywords:

Cancer Immunotherapy Mouse tumor model Tertiary lymphoid structure

More Related Videos

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Feb 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Area of Science:

Immunology
Oncology
Cancer Research

Background:

Tumor microenvironments (TME) are typically immunosuppressive, hindering anti-cancer immune responses.
Cancer immunotherapy, including immune checkpoint inhibitors, has shown success in various cancers.
Tertiary lymphoid structures (TLS) are associated with inflammation and can promote anti-tumor immunity.

Purpose of the Study:

To describe methods for establishing transplantable mouse tumor models for immunotherapy research.
To introduce therapeutic strategies targeting TLS for enhanced anti-tumor immunity.
To present methods for evaluating immune responses to TLS-targeted therapies.

Main Methods:

Establishment of transplantable mouse tumor models.
Implementation of systemic and local therapeutic strategies targeting TLS.
Evaluation of anti-tumor immune responses.

Main Results:

TLS formation facilitates lymphocyte trafficking, antigen presentation, and activation within tumors.
Therapeutics targeting TLS have demonstrated promising anti-tumor effects in preclinical models.
The described methods allow for the study of TLS manipulation in cancer immunotherapy.

Conclusions:

TLS are crucial structures for orchestrating anti-tumor immune responses.
Targeting TLS represents a viable strategy to enhance the effectiveness of cancer immunotherapy.
The presented models and methods support further research into TLS-based cancer therapies.